1-3 of 3
Philipp Nakov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pseudoprogression As Adverse Event of Chimeric Antigen Receptor T Cell Therapy

Torsten Schroeder, Tjark Martens, Guranda Chitadze, Fatih Yalcin, Heiko Trautmann, Monika Brüggemann, Christine Heinen, Philipp Nakov, Anca Maria Albici, Nicolas Spath, Lukas Sprenger, Laura Jane Kramp, Matthias Ritgen, Dominique Wellnitz, Maciej Simon, Sebastian Lippross, Ingram Iaccarino, Wolfram Klapper, Lars Fransecky, Thomas Valerius, Natalie Schub, Christiane Pott, Claudia D Baldus, Friedrich Stoelzel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6935.
https://doi.org/10.1182/blood-2023-189047
Published: 2023
Journal Articles

Venetoclax and Blinatumomab for Adult Patients with Relapsed/Refractory or MRD Positive Ph-Negative B-Precursor ALL: First Results of the GMALL-Bliven Trial

Lars Fransecky, Walter Fiedler, Christoph Röllig, Tim Sauer, Simon Raffel, Winfried Alsdorf, Lisa Heberling, Kumaran Nagarajan, Britta Steer, Philipp Nakov, Björn Steffen, Dorothee Deckbar, Sonja Bendig, Lorenz Bastian, Martin Neumann, Monika Brueggemann, Nicola Goekbuget, Claudia D Baldus
Journal: Blood
Blood (2023) 142 (Supplement 1): 1502.
https://doi.org/10.1182/blood-2023-173937
Published: 2023
Journal Articles

An Open Label Study Comparing Photobiomodulation Therapy to Cryotherapy in Patients at High Risk for Drug-Induced Oral Mucositis

Philipp Nakov, Ruth Lando, Torsten Schroeder, Lasse Jost, Lauritz Miarka, David Baden, Cornelia Baden, Nassim Kakavand, Enrique Restrepo-Salamaca, Alina Kloth, Anca Maria Albici, Laura Jane Kramp, Felix Brachaczek, Julia Feuerborn, Carsten Haack, Claudia Schmalz, Stephanie Busch, Friedrich Stoelzel, Claudia D Baldus, Lars Fransecky
Journal: Blood
Blood (2023) 142 (Supplement 1): 7081.
https://doi.org/10.1182/blood-2023-180110
Published: 2023